Metamorfosis ALK: desafío diagnóstico y terapéutico
GECP Lung Cancer & Clinical Research Journal · 04.08.2026 · 2 (1)
DOI: 10.24875/gecplc.m26000020 ↗Kurz gefasst
Fachartikel in der Zeitschrift GECP Lung Cancer & Clinical Research Journal, online erschienen am 04.08.2026. Verfasst von Anna Estival-González und 7 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Estival-González, A., Rodríguez-Abreu, D., Guadalupe-Guadalupe, E., Hermoso-Rodríguez, L., Camacho-García, M. C., Andújar-Sánchez, M., Karani-Narain, N., & Soto-Rojas, P. (2026). Metamorfosis ALK: desafío diagnóstico y terapéutico. GECP Lung Cancer & Clinical Research Journal, 2(1). https://doi.org/10.24875/gecplc.m26000020
Vancouver
Estival-González A, Rodríguez-Abreu D, Guadalupe-Guadalupe E, Hermoso-Rodríguez L, Camacho-García MC, Andújar-Sánchez M, et al. Metamorfosis ALK: desafío diagnóstico y terapéutico. GECP Lung Cancer & Clinical Research Journal. 2026;2(1). doi:10.24875/gecplc.m26000020
BibTeX
@article{EstivalGonzlez2026,
author = {Estival-González, Anna and Rodríguez-Abreu, Delvys and Guadalupe-Guadalupe, Elisa and Hermoso-Rodríguez, Luis and Camacho-García, M.ª Carmen and Andújar-Sánchez, Miguel and Karani-Narain, Nikhil and Soto-Rojas, Pilar},
title = {Metamorfosis ALK: desafío diagnóstico y terapéutico},
journal = {GECP Lung Cancer & Clinical Research Journal},
year = {2026},
volume = {2},
number = {1},
doi = {10.24875/gecplc.m26000020}
}
EUVIMED